Results 51 to 60 of about 152 (112)

[Management of cutaneous and systemic involvement by Candida auris]. [PDF]

open access: yesRev Esp Quimioter, 2022
Roig Martí C   +5 more
europepmc   +1 more source

Hyperbaric oxygen therapy as an adjunctive treatment for COVID-19-associated mucormycosis: a report of two cases. [PDF]

open access: yesRev Peru Med Exp Salud Publica, 2023
Valencia-Caballero V   +9 more
europepmc   +1 more source

Evidence map of diagnosis, treatment, prognosis, prevention, and control in visceral leishmaniasis. [PDF]

open access: yesRev Panam Salud Publica, 2022
Ibiapina AB   +6 more
europepmc   +1 more source

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes. [PDF]

open access: yesPharmaceutics, 2022
Ramos GS   +11 more
europepmc   +1 more source

Unexpected cause of ischemic lesions in an immunocompetent patient. [PDF]

open access: yesEnferm Infecc Microbiol Clin (Engl Ed), 2021
Bustos-Merlo A   +2 more
europepmc   +1 more source

[Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19]. [PDF]

open access: yesRev Esp Anestesiol Reanim, 2022
Sánchez Martín C   +5 more
europepmc   +1 more source

[Multisystem inflammatory syndrome in adults associated to SARS-CoV-2]. [PDF]

open access: yesEnferm Infecc Microbiol Clin, 2022
Llenas-García J   +3 more
europepmc   +1 more source

[Importance of Contrast-Enhanced CT in the Early Diagnosis of Pulmonary Mucormycosis: A Case Report]. [PDF]

open access: yesOpen Respir Arch, 2021
Porta Vilaró M   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy